Weijun Xu

3.6k total citations · 1 hit paper
119 papers, 2.9k citations indexed

About

Weijun Xu is a scholar working on Management Science and Operations Research, Biomedical Engineering and Biomaterials. According to data from OpenAlex, Weijun Xu has authored 119 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Management Science and Operations Research, 39 papers in Biomedical Engineering and 31 papers in Biomaterials. Recurrent topics in Weijun Xu's work include Nanoplatforms for cancer theranostics (25 papers), Nanoparticle-Based Drug Delivery (21 papers) and Risk and Portfolio Optimization (18 papers). Weijun Xu is often cited by papers focused on Nanoplatforms for cancer theranostics (25 papers), Nanoparticle-Based Drug Delivery (21 papers) and Risk and Portfolio Optimization (18 papers). Weijun Xu collaborates with scholars based in China, Hong Kong and Australia. Weijun Xu's co-authors include Junmin Qian, Aili Suo, Jinlei Wang, Guanghui Hou, Yaping Wang, Yong‐Jun Liu, Lijie Ji, Wei-Guo Zhang, Tiantian Sun and Yu Yao and has published in prestigious journals such as Nature Communications, ACS Nano and Advanced Functional Materials.

In The Last Decade

Weijun Xu

114 papers receiving 2.8k citations

Hit Papers

A Hollow Amorphous Bimetal Organic Framework for Synergis... 2022 2026 2023 2024 2022 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weijun Xu China 32 1.2k 880 658 491 436 119 2.9k
Xun Lu China 31 768 0.6× 709 0.8× 28 0.0× 688 1.4× 490 1.1× 124 3.1k
Xuetao Li China 34 423 0.4× 665 0.8× 104 0.2× 999 2.0× 254 0.6× 168 3.4k
Jie Zhang China 31 195 0.2× 160 0.2× 275 0.4× 199 0.4× 109 0.3× 278 3.9k
Sang‐Joon Kim South Korea 26 627 0.5× 64 0.1× 159 0.2× 286 0.6× 260 0.6× 88 3.7k
Xiaoli Tian China 29 701 0.6× 89 0.1× 525 0.8× 224 0.5× 823 1.9× 74 2.7k
Chen Zhao United States 23 297 0.2× 112 0.1× 98 0.1× 1.4k 2.8× 353 0.8× 81 3.3k
Ping Li China 31 1.4k 1.1× 1.2k 1.3× 156 0.2× 443 0.9× 384 0.9× 191 3.3k
Chonghui Zhang China 27 237 0.2× 19 0.0× 714 1.1× 331 0.7× 185 0.4× 156 2.4k
Shuo Hu China 33 1.1k 0.9× 342 0.4× 34 0.1× 1.4k 2.9× 488 1.1× 214 4.4k
David Williams United Kingdom 39 740 0.6× 268 0.3× 28 0.0× 998 2.0× 782 1.8× 280 5.2k

Countries citing papers authored by Weijun Xu

Since Specialization
Citations

This map shows the geographic impact of Weijun Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weijun Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weijun Xu more than expected).

Fields of papers citing papers by Weijun Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weijun Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weijun Xu. The network helps show where Weijun Xu may publish in the future.

Co-authorship network of co-authors of Weijun Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Weijun Xu. A scholar is included among the top collaborators of Weijun Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weijun Xu. Weijun Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Qi, et al.. (2025). Do green bonds have an advantage in information disclosure?. International Review of Financial Analysis. 101. 104008–104008. 2 indexed citations
2.
Xu, Weijun, et al.. (2025). Digital finance and corporate labor costs: An analysis from the perspective of financing channels. International Review of Economics & Finance. 105. 104808–104808.
3.
Xu, Weijun, et al.. (2025). Driving ESG Excellence: Analysing China's Green Finance Policy With Double/Debiased Machine Learning. International Journal of Finance & Economics. 31(1). 1333–1346. 1 indexed citations
4.
Wang, Jinlei, Weijun Xu, Junmin Qian, et al.. (2025). Copper peroxide/manganese dioxide nanoparticles crosslinked hyaluronan hydrogel for enhanced chemodynamic/photodynamic/photothermal therapy in breast cancer. Journal of Colloid and Interface Science. 703(Pt 1). 139121–139121.
5.
Xu, Weijun, et al.. (2024). Online Portfolio Based on Trend Trading Strategy Considering Investor Sentiment Using Text Analysis. International Journal of Fuzzy System Applications. 13(1). 1–20.
6.
Chen, Xin, Weijun Xu, & Meng Wu. (2024). Newsvendor overconfidence and advertising. Omega. 126. 103071–103071. 4 indexed citations
7.
Xu, Weijun, et al.. (2023). Distributed mean reversion online portfolio strategy with stock network. European Journal of Operational Research. 314(3). 1143–1158. 1 indexed citations
8.
Xu, Weijun, et al.. (2023). Public disclosure with information sharing in financial market. Finance research letters. 53. 103652–103652. 1 indexed citations
9.
Wang, Jinlei, Weijun Xu, Junmin Qian, et al.. (2022). Injectable hyaluronan/MnO2 nanocomposite hydrogel constructed by metal-hydrazide coordinated crosslink mineralization for relieving tumor hypoxia and combined phototherapy. Journal of Colloid and Interface Science. 628(Pt B). 79–94. 21 indexed citations
10.
Hou, Guanghui, Junmin Qian, Min Guo, et al.. (2022). Hydrazide-manganese coordinated multifunctional nanoplatform for potentiating immunotherapy in hepatocellular carcinoma. Journal of Colloid and Interface Science. 628(Pt B). 968–983. 15 indexed citations
11.
Hou, Guanghui, Junmin Qian, Min Guo, et al.. (2021). Hydrazided hyaluronan/cisplatin/indocyanine green coordination nanoprodrug for photodynamic chemotherapy in liver cancer. Carbohydrate Polymers. 276. 118810–118810. 31 indexed citations
12.
Xu, Weijun, Junmin Qian, Guanghui Hou, et al.. (2018). PEGylated hydrazided gold nanorods for pH-triggered chemo/photodynamic/photothermal triple therapy of breast cancer. Acta Biomaterialia. 82. 171–183. 58 indexed citations
13.
Cui, Ning, et al.. (2016). Preparation, physicochemical properties and biocompatibility of PBLG/PLGA/bioglass composite scaffolds. Materials Science and Engineering C. 71. 118–124. 23 indexed citations
14.
Liu, Xiaoming, Jing Li, Yuming Zhang, et al.. (2016). GS/DBM/PLA porous composite biomaterial for the treatment of infective femoral condyle defect in rats. Experimental and Therapeutic Medicine. 11(6). 2107–2116. 10 indexed citations
15.
Xu, Weijun, et al.. (2014). Optimal Portfolio Strategy under Rolling Economic Maximum Drawdown Constraints. Mathematical Problems in Engineering. 2014(1). 3 indexed citations
16.
Qian, Junmin, et al.. (2013). Preparation and characterization of bimodal porous poly(γ-benzyl-L-glutamate) scaffolds for bone tissue engineering. Materials Science and Engineering C. 33(8). 4587–4593. 36 indexed citations
17.
Xu, Weijun, Xiaolong Peng, & Weilin Xiao. (2013). The Fuzzy Jump-Diffusion Model to Pricing European Vulnerable Options. International Journal of Fuzzy Systems. 15(3). 317–325. 7 indexed citations
18.
Zhang, Weiguo, et al.. (2011). Risk–reward models for on-line leasing of depreciable equipment. Computers & Mathematics with Applications. 63(1). 167–174. 6 indexed citations
19.
Zhang, Yong, Wei-Guo Zhang, Weijun Xu, & Hongyi Li. (2011). Competitive strategy for on-line leasing of depreciable equipment. Mathematical and Computer Modelling. 54(1-2). 466–476. 12 indexed citations
20.
Lei, Xin, et al.. (2007). Experiment study of forming and activation of conductive film of the surface conduction electron emitter display. Optoelectronics Letters. 3(1). 54–56. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026